ReviewPediatric nephrology (Berlin, Germany)2010
C1q nephropathy in the pediatric population: pathology and pathogenesis.
Review in Pediatric nephrology (Berlin, Germany), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 34 citations in OpenAlex.
- The natural history of immunoglobulin M nephropathy in adults.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2017Trial
- Distinct Complement Activation Profiles Between NELL1- and PLA2R-Associated Membranous Nephropathy: A Clinicopathological and Proteomic Study.Nephrology (Carlton, Vic.) · 2026Article
- Article
- Hepatic tuberculosis induced by rituximab treatment for C1q nephropathy with minimal change disease: a case report.Frontiers in medicine · 2025Article
- Pediatric Bilateral Hypoplastic Kidney Complicated With C1q Nephropathy: A Case Report.Cureus · 2024Article
- Identification of biomarkers of chronic kidney disease among kidney-derived proteins.Clinical proteomics · 2022Article
- Renal Outcome of IgM Nephropathy: A Comparative Prospective Cohort Study.Journal of clinical medicine · 2021Article
- APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.Pediatric nephrology (Berlin, Germany) · 2021Article
- C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics.PloS one · 2019Article
- [Advances in clinical research on C1q nephropathy].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2016Review
- Pathology of Podocytopathies Causing Nephrotic Syndrome in Children.Frontiers in pediatrics · 2016Review
- Article
- C1q nephropathy in children: clinical characteristics and outcome.Pediatric nephrology (Berlin, Germany) · 2014Article
- Do C1q or IgM nephropathies predict disease severity in children with minimal change nephrotic syndrome?Pediatric nephrology (Berlin, Germany) · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
C1q nephropathy was originally described nearly 25 years ago by Jennette and Hipp. Since that time there have been a limited number of publications on C1q nephropathy, most of them in the pediatric literature. Despite reported incidences as high as 16% in some pediatric biopsy series, a consensus definition on the diagnosis of C1q nephropathy is lacking and its existence as a distinct clinical disease entity remains controversial. The purpose of this review is to discuss the biology of C1q in the context of mechanisms of C1q deposition, and to provide a detailed analysis of the published pediatric case series with a focus on the pathological criteria used to establish the diagnosis of C1q nephropathy as well as long-term outcomes in children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.